Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Trial of Moxifloxacin for Tb
Chaisson, Richard E.
Johns Hopkins University, Baltimore, MD, United States
Search 146 grants from Richard Chaisson
Search grants from Johns Hopkins University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Computational and statistical models for human genetics
Lentiviral Vectors for Position-Independent Expression
Analysis of Sensory Neuron Development
Primary HHV6 Infection - Clinical & Viral Characteristics
Protein Functional Domains in Eukaryotic Ribosomes
Recently added grants:
A Problem Solving Intervention for Hospice Caregivers
Longitudinal neuroimaging in Sturge-Weber syndrome
Newborn Neurons in the Adult Hippocampal Network
Mapping Connectivity Onto Postnatal-Born Neurons
Cellular Regulation of Sodium-activated Potassium Channels
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Research Project (R01)
Project #
5R01FD002135-03
Application #
7128910
Study Section
Special Emphasis Panel (ZFD1-SRC (99))
Program Officer
Needleman, Katherine
Project Start
2003-09-30
Project End
2007-04-30
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
3
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Related projects
NIH 2007
R01 FD
Phase II Trial of Moxifloxacin for Tb
Chaisson, Richard E. / Johns Hopkins University
NIH 2006
R01 FD
Phase II Trial of Moxifloxacin for Tb
Chaisson, Richard E. / Johns Hopkins University
Publications
Conde, Marcus B; Efron, Anne; Loredo, Carla et al.
(2009)
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.
Lancet 373:1183-9
Comments
Be the first to comment on Richard Chaisson's grant